尿道バルキング装置の世界市場2022年~2029年:疾患別、薬剤別、エンドユーザー別、地域別

◆英語タイトル:Global Urethral Bulking System Market Size study & Forecast, by Disease Type (Stress urinary incontinence, Urge incontinence, Overflow incontinence, Functional incontinence, others), By Agent (Bulkamid, Coaptite, Durasphere, Macroplastique, Others), By End-Use (Hospitals, Clinics, Ambulatory Surgical Centers, Others), and Regional Analysis, 2022-2029

Bizwit Research & Consultingが発行した調査報告書(BZW23MA113)◆商品コード:BZW23MA113
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2023年4月1日
◆ページ数:約200
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥752,400見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥950,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ビズウィットリサーチ社の本調査レポートでは、2021年にXXX百万ドルであった世界の尿道バルキング装置市場規模が、2022年〜2029年の間に年平均XXX%で拡大すると推測しています。本レポートは、尿道バルキング装置の世界市場について徹底的に調査を行い、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、疾患別(腹圧性尿失禁、切迫性尿失禁、溢流性尿失禁、機能性尿失禁、その他)分析、薬剤別(ブルカミド、Coaptite、Durasphere、Macroplastique、その他)分析、エンドユーザー別(病院、診療所、外来手術センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他地域)分析、競争分析、調査プロセスなど、以下の構成でまとめています。また、本書は、Boston Scientific Corporation 、Contura International Ltd.、Coloplast Corp、CR Bard, Inc.、Merz Aesthetics Inc.、Cogentix Medical Inc.、Uroplasty, Inc.、Q-Med AB、ASCENTX MEDICAL, INC.,、AstraZeneca Plc.などの企業情報を含んでいます。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の尿道バルキング装置市場規模:疾患別
- 腹圧性尿失禁の市場規模
- 切迫性尿失禁の市場規模
- 溢流性尿失禁の市場規模
- 機能性尿失禁の市場規模
- その他疾患の市場規模
・世界の尿道バルキング装置市場規模:薬剤別
- ブルカミドの市場規模
- Coaptiteの市場規模
- Durasphereの市場規模
- Macroplastiqueの市場規模
- その他薬剤の市場規模
・世界の尿道バルキング装置市場規模:エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の尿道バルキング装置市場規模:地域別
- 北米の尿道バルキング装置市場規模
- ヨーロッパの尿道バルキング装置市場規模
- アジア太平洋の尿道バルキング装置市場規模
- 中南米の尿道バルキング装置市場規模
- その他地域の尿道バルキング装置市場規模
・競争分析
・調査プロセス

Global Urethral Bulking System Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XXX over the forecast period 2022-2029. The urethral bulking system is a medical device used to treat urinary incontinence in women. The system involves injecting bulking agents, such as collagen or silicone, into the walls of the urethra to create a bulge that helps to prevent leakage of urine. Urinary incontinence is a common condition that can be caused by a variety of factors, such as childbirth, aging, or surgery. It occurs when the muscles that control the bladder become weak or damaged, leading to the involuntary leakage of urine. The market demand is primarily driven by the factors such as Non-surgical treatment options that can be performed without general anaesthesia, coupled with minimal side effects.

In addition, increasing cases of urethral incontinence in females. Menopause, hysterectomy, pregnancy, and childbirth are a few of the main underlying health issues that cause urethral incontinence in women. Moreover, a changed lifestyle is a key cause of urethral incontinence is acting as a major driving factor for market growth. According to NCBI, as of 2022, Over 423 million adults (20 years and older) worldwide are thought to suffer from urine incontinence. Between 24 and 45 per cent of women report having some level of incontinence. Women between the ages of 20 and 39 who report urine incontinence range from 7% to 37%. 9% to 39% of women over 60 reports having daily incontinence, thus, in turn, these factors are expected to escalate the demand for vaccines in the global market. Furthermore, growing demand for minimally invasive treatments, as well as Advancements in technology leading to new products and treatment options are presenting lucrative opportunities for market growth over the forthcoming years. However, healthcare providers may be unaware of the urethral bulking system or its benefits are restricting the market growth over the forecast period of 2022-2029.

The key regions considered for the Global Urethral Bulking System Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to an increase in the prevalence of urine incontinence in adults, the availability of novel bulking gel, improvements in technology, and the success or result of bulking agents in treating urinary continence conditions. Presence of major players selling kits for urethral bulking systems. Whereas, Asia Pacific is also expected to grow at the highest growth rate over the forecasting period. Factor such as Stress urine incontinence is becoming more common among both men and women in the region and is burgeoning the market growth in the forecasting years.

Major market players included in this report are:
Boston Scientific Corporation
Contura International Ltd.
Coloplast Corp
CR Bard, Inc.
Merz Aesthetics Inc.
Cogentix Medical Inc.
Uroplasty, Inc.
Q-Med AB
ASCENTX MEDICAL, INC.,
AstraZeneca Plc.

Recent Developments in the Market:
 In February 2023, AstraZeneca announced the successful completion of its purchase of CinCor Pharma, Inc., a clinical-stage biopharmaceutical company with operations in the US that specialises in the research and development of innovative therapies for resistant and uncontrolled hypertension as well as chronic kidney disease.
 In December 2022, Boston Scientific Corporation and Acotec Scientific Holdings Limited have announce that Boston Scientific will make a partial offer to purchase a majority stake in Acotec, a Chinese medical technology company that provides solutions for various interventional procedures, up to a maximum of 65% of the company’s shares. Both businesses will have prospects for expansion as a result of this investment.
 In October 2022, BD India, a leading provider of medical technology, teamed up with Raja Ramanna Centre for Advanced Technology (RRCAT), a famous government research institute, to sterilise one of its medical devices, Venflon Pro, using an electron beam (e-beam) technology at RRCAT’s Indore site. The scientists and engineers at RRCAT created and constructed the full e-beam facility. It is the only such facility in India that is certified to ISO 13485 and has regulatory approval for irradiating Class A and Class B medical equipment. This important relationship is a turning point in medical equipment manufacturers’ understanding of e-beam technology’s advantages in the nation. Also, it might improve India’s local infrastructure for processing equipment, allowing the Prime Minister’s vision of Atmanirbharta to come true.

Global Urethral Bulking System Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Disease Type, Agent, End-Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:
Stress urinary incontinence
Urge incontinence
Overflow incontinence
Functional incontinence
Others

By Agent:
Bulkamid
Coaptite
Durasphere
Macroplastique
Others

By End-Use:
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Urethral Bulking System Market, by Region, 2019-2029 (USD Million)
1.2.2. Urethral Bulking System Market, by Disease Type, 2019-2029 (USD Million)
1.2.3. Urethral Bulking System Market, by Agent, 2019-2029 (USD Million)
1.2.4. Urethral Bulking System Market, by End-Use, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Urethral Bulking System Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Urethral Bulking System Market Dynamics
3.1. Urethral Bulking System Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Non-surgical treatment option.
3.1.1.2. Minimal side effects.
3.1.1.3. Increasing cases of urethral incontinence in females.
3.1.2. Market Challenges
3.1.2.1. Lack of awareness about the system.
3.1.3. Market Opportunities
3.1.3.1. Growing demand for minimally invasive treatments.
3.1.3.2. Regular Advancements in technology.
Chapter 4. Global Urethral Bulking System Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Urethral Bulking System Market, by Disease Type
6.1. Market Snapshot
6.2. Global Urethral Bulking System Market by Disease Type, Performance – Potential Analysis
6.3. Global Urethral Bulking System Market Estimates & Forecasts by Disease Type 2019-2029 (USD Million)
6.4. Urethral Bulking System Market, Sub Segment Analysis
6.4.1. Stress urinary incontinence
6.4.2. Urge incontinence
6.4.3. Overflow incontinence
6.4.4. Functional incontinence
6.4.5. Others
Chapter 7. Global Urethral Bulking System Market, by Agent
7.1. Market Snapshot
7.2. Global Urethral Bulking System Market by Agent, Performance – Potential Analysis
7.3. Global Urethral Bulking System Market Estimates & Forecasts by Agent 2019-2029 (USD Million)
7.4. Urethral Bulking System Market, Sub Segment Analysis
7.4.1. Bulkamid
7.4.2. Coaptite
7.4.3. Durasphere
7.4.4. Macroplastique
7.4.5. Others
Chapter 8. Global Urethral Bulking System Market, by End-Use
8.1. Market Snapshot
8.2. Global Urethral Bulking System Market by End-Use, Performance – Potential Analysis
8.3. Global Urethral Bulking System Market Estimates & Forecasts by End-Use 2019-2029 (USD Million)
8.4. Urethral Bulking System Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Ambulatory Surgical Certers
8.4.4. Others
Chapter 9. Global Urethral Bulking System Market, Regional Analysis
9.1. Urethral Bulking System Market, Regional Market Snapshot
9.2. North America Urethral Bulking System Market
9.2.1. U.S. Urethral Bulking System Market
9.2.1.1. Disease Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Agent breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-Use breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Urethral Bulking System Market
9.3. Europe Urethral Bulking System Market Snapshot
9.3.1. U.K. Urethral Bulking System Market
9.3.2. Germany Urethral Bulking System Market
9.3.3. France Urethral Bulking System Market
9.3.4. Spain Urethral Bulking System Market
9.3.5. Italy Urethral Bulking System Market
9.3.6. Rest of Europe Urethral Bulking System Market
9.4. Asia-Pacific Urethral Bulking System Market Snapshot
9.4.1. China Urethral Bulking System Market
9.4.2. India Urethral Bulking System Market
9.4.3. Japan Urethral Bulking System Market
9.4.4. Australia Urethral Bulking System Market
9.4.5. South Korea Urethral Bulking System Market
9.4.6. Rest of Asia Pacific Urethral Bulking System Market
9.5. Latin America Urethral Bulking System Market Snapshot
9.5.1. Brazil Urethral Bulking System Market
9.5.2. Mexico Urethral Bulking System Market
9.5.3. Rest of Latin America Urethral Bulking System Market
9.6. Rest of The World Urethral Bulking System Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Boston Scientific Corporation
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Contura International Ltd.
10.2.3. Coloplast Corp
10.2.4. CR Bard, Inc.
10.2.5. Merz Aesthetics Inc.
10.2.6. Cogentix Medical Inc.
10.2.7. Uroplasty, Inc.
10.2.8. Q-Med AB
10.2.9. ASCENTX MEDICAL, INC.,
10.2.10. AstraZeneca Plc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 尿道バルキング装置の世界市場2022年~2029年:疾患別、薬剤別、エンドユーザー別、地域別(Global Urethral Bulking System Market Size study & Forecast, by Disease Type (Stress urinary incontinence, Urge incontinence, Overflow incontinence, Functional incontinence, others), By Agent (Bulkamid, Coaptite, Durasphere, Macroplastique, Others), By End-Use (Hospitals, Clinics, Ambulatory Surgical Centers, Others), and Regional Analysis, 2022-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆